Biosimilars in the United States: A brief look at where we are and the road ahead

被引：5

作者：

Morrison, Alan J.

机构：

来源：

BIOTECHNOLOGY LAW REPORT | 2007年 / 26卷 / 05期

关键词：

D O I：

10.1089/blr.2007.9914

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

[No abstract available]

引用

页码：463 / 467

页数：5

共 50 条

[31] COVID-19 in the United States: Where are we now? Where have we been?
Bloomgarden, Zachary
JOURNAL OF DIABETES, 2021, 13 (02) : 98 - 100
[32] The three Rs in research and education: A long road ahead in the United States
Orlans, FB
ATLA-ALTERNATIVES TO LABORATORY ANIMALS, 1996, 24 (02): : 151 - 158
[33] Two nations indivisible: Mexico, the United States, and the road ahead.
Wood, Duncan
INTERNATIONAL AFFAIRS, 2014, 90 (06) : 1504 - 1505
[34] TECHNOLOGY FORECASTING .6. WHERE TO LOOK TO LOOK AHEAD
LINSTONE, HA
IEEE SPECTRUM, 1975, 12 (04) : 60 - 61
[35] A look at where we came from and where we are going
Goolsby, C
CYTOMETRY PART A, 2004, 58A (01): : 53 - 54
[36] Food Insecurity Research in the United States: Where We Have Been and Where We Need to Go
Gundersen, Craig
Ziliak, James P.
APPLIED ECONOMIC PERSPECTIVES AND POLICY, 2018, 40 (01) : 119 - 135
[37] Where did we come from? Where are we going? Reflections on Galician studies in the United States
Colmeiro, Jose
MADRYGAL-REVISTA DE ESTUDIOS GALLEGOS, 2013, 16 : 131 - 138
[38] Maternal mortality in the United States: Where are we going and how will we get there?
Hawkins, JL
Birnbach, DJ
ANESTHESIA AND ANALGESIA, 2001, 93 (01): : 1 - 3
[39] An Opportunity Missed: Biosimilars in the United States
Goll, Guro L.
Kvien, Tore K.
ARTHRITIS & RHEUMATOLOGY, 2020, 72 (07) : 1046 - 1048
[40] Biosimilars in Oncology in the United States A Review
Nabhan, Chadi
Parsad, Sandeep
Mato, Anthony R.
Feinberg, Bruce A.
JAMA ONCOLOGY, 2018, 4 (02) : 241 - 247

← 1 2 3 4 5 →